FDA approves Johnson & Johnson’s single-shot Covid vaccine for emergency use

The United States Food and Drug Administration (FDA) approved the coronavirus vaccine developed by Johnson & Johnson for emergency use, making it the third jab with such designation in the US.

FDA’s advisory board approved the jab for the Emergency Use Authorization on Friday.  Johnson & Johnson’s COVID jab makes the vaccination process somewhat less challenging than in the case of the vaccines made by Moderna or Pfizer, as it requires a single dose, and doesn’t need to be stored at ultra-low temperatures.

“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” Acting FDA Commissioner Janet Woodcock commented.